Prostatic abscess: clinical features, management, and outcomes of a “Stealth” infection: retrospective case series and review of the literature

2021 ◽  
Vol 99 (4) ◽  
pp. 115285
Author(s):  
Margaux E. Wooster ◽  
Glen Huang ◽  
John W. Sanders ◽  
James E. Peacock
2020 ◽  
Vol 133 ◽  
pp. e702-e710
Author(s):  
Michelle Lin ◽  
Joshua Bakhsheshian ◽  
Ben Strickland ◽  
Robert C. Rennert ◽  
Jefferson W. Chen ◽  
...  

2008 ◽  
Vol 98 (3) ◽  
pp. 212-223 ◽  
Author(s):  
Rolf W. Scharfbillig ◽  
Sara Jones ◽  
Sheila D. Scutter

Background: Sever’s disease is typical of many musculoskeletal conditions where observational annotations have slowly been accepted as fact with the passing of years. Acceptance of these nontested observations means that health professionals seeking information on this condition access very low-level evidence, mainly being respectable opinion or poorly conducted retrospective case series. Methods: A comprehensive review of the literature was undertaken gathering available articles and book references relating to Sever’s disease. This information was then reviewed to present what is actually known about this condition. Results: Respectable opinion and poorly conducted retrospective case series make up the majority of evidence on this condition. Conclusion: The level of evidence for most of what we purport to know about Sever’s disease is at such a level that prospective, well-designed studies are a necessity to allow any confidence in describing this condition and its treatment. (J Am Podiatr Med Assoc 98(3): 212–223, 2008)


Pain Practice ◽  
2002 ◽  
Vol 2 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Mike A. Royal ◽  
Bhadresh Bhakta ◽  
Ian Gunyea ◽  
Mike Jenson ◽  
Venkatesh Movva ◽  
...  

2020 ◽  
Vol 24 (3) ◽  
pp. 272-276
Author(s):  
Sarah Platt ◽  
Sarah Coleridge ◽  
Geoff Hughes ◽  
Hannah Donkers ◽  
Alison Wiggans ◽  
...  

2020 ◽  
Vol 8 (T1) ◽  
pp. 16-22
Author(s):  
Samad Karkhah ◽  
Mohammad Javad Ghazanfari ◽  
Amir Shamshirian ◽  
Latif Panahi ◽  
Meysam Molai ◽  
...  

BACKGROUND: Coronavirus disease-19 (COVID-19) is the first pandemic infectious disease caused by a novel coronavirus. Viral pneumonia is a severe complication of COVID-19. AIM: Due to the high prevalence of this disease globally, especially in Iran, the aim of this study was to determine the clinical features of seven patients with probable COVID-19 infected pneumonia in Rasht, North Iran. MATERIALS AND METHODS: In this retrospective case series study, we described the clinical, laboratory, and radiological features of seven patients with probable COVID-19 infected pneumonia at Razi Hospital, Rasht, north of Iran, from February 27 to March 16, 2020. RESULTS: In this study, the most common clinical symptoms during hospitalization in patients with COVID-19 were poor appetite (seven cases), dehydration (seven cases), cough (six cases), dyspnea (six cases), fatigue (six cases), fever above 38°C (five cases), myalgia (five cases), Chills (five cases), feeling fever (five cases), sore throat (five cases), and nausea (five cases), respectively. The average body temperature in these patients was 39.32°C. In laboratory findings, erythrocyte sedimentation rate was elevated in three patients. Contrary to most of the evidence, C-reactive protein was not elevated in five patients. All patients received antibiotic and antiviral medications and received symptomatic treatment. Finally, four patients responded to the treatments and were discharged from the hospital; two patients were still hospitalized and only one patient died. CONCLUSION: Patients with COVID-19 associated pneumonia can be treated by evaluating and implementing appropriate therapeutic management. However, at the moment the disease progression for patients with COVID-19 cannot be accurately predicted.


Sign in / Sign up

Export Citation Format

Share Document